Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M317Revenue (TTM) $M30.7Net Margin (%)-303.5Altman Z-Score2.3
Enterprise Value $M169EPS (TTM) $-3.2Operating Margin %-298.3Piotroski F-Score2
P/E(ttm)--Beneish M-Score1.4Pre-tax Margin (%)-297.9Higher ROA y-yN
Price/Book2.310-y EBITDA Growth Rate %--Quick Ratio4.4Cash flow > EarningsY
Price/Sales10.25-y EBITDA Growth Rate %--Current Ratio4.4Lower Leverage y-yY
Price/Free Cash Flow--y-y EBITDA Growth Rate %-171.3ROA % (ttm)-46.1Higher Current Ratio y-yN
Dividend Yield %--PEG--ROE % (ttm)-53.7Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M29.1ROIC % (ttm)--Gross Margin Increase y-yN

Gurus Latest Trades with NLNK

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
NLNKFirst Eagle Investment 2016-06-30 Add0.01%$9.71 - $19.39
($13.84)
$ 11.04-20%Add 24.62%2,186,700
NLNKFirst Eagle Investment 2016-03-31 Reduce$16.51 - $36.39
($22.76)
$ 11.04-51%Reduce -2.15%1,754,700
NLNKFirst Eagle Investment 2015-12-31 Reduce-0.01%$32.73 - $44.93
($36.21)
$ 11.04-70%Reduce -4.44%1,793,200
NLNKJoel Greenblatt 2015-09-30 Sold Out -0.46%$35.26 - $55.01
($48.76)
$ 11.04-77%Sold Out0
NLNKFirst Eagle Investment 2015-09-30 Add0.01%$35.26 - $55.01
($48.76)
$ 11.04-77%Add 9.13%1,876,600
NLNKJoel Greenblatt 2015-06-30 Add0.15%$36.55 - $56.87
($47.33)
$ 11.04-77%Add 48.51%1,244,856
NLNKFirst Eagle Investment 2015-06-30 Add0.03%$36.55 - $56.87
($47.33)
$ 11.04-77%Add 20.19%1,719,600
NLNKJoel Greenblatt 2015-03-31 Buy 0.35%$31.95 - $56.4
($43.06)
$ 11.04-74%New holding838,221
NLNKFirst Eagle Investment 2015-03-31 Add$31.95 - $56.4
($43.06)
$ 11.04-74%Add 1.73%1,430,700
NLNKFirst Eagle Investment 2014-03-31 Add0.02%$21.38 - $50.4
($33.68)
$ 11.04-67%Add 28.35%1,161,805
NLNKFirst Eagle Investment 2013-09-30 Add0.01%$15.78 - $20.08
($17.83)
$ 11.04-38%Add 21.32%778,354
NLNKFirst Eagle Investment 2013-06-30 Add0.02%$11.27 - $22.56
($15.73)
$ 11.04-30%Add 95.04%641,554
NLNKFirst Eagle Investment 2013-03-31 Buy 0.01%$11.4 - $12.7
($12.08)
$ 11.04-9%New holding328,939
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

NLNK is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


NLNK: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Talarico Ernest IIIDirector 2016-06-06Buy4,065$12.32-11.04view
Link Charles J. Jr.Chairman of the Board and CEO 2016-04-07Sell10,000$20.03-45.28view
Link Charles J. Jr.Chairman of the Board and CEO 2016-03-15Sell25,000$17.86-38.63view
Link Charles J. Jr.Chairman of the Board and CEO 2016-02-03Sell25,000$24.16-54.64view
HENNEMAN JOHN B IIIEVP, CFO 2016-01-05Sell175$35.74-69.33view
Wiley BrianVP of Business Development 2016-01-05Sell1,295$34.99-68.68view
Vahanian Nicholas N.President, Chief Medical Offic 2016-01-05Sell3,011$35.06-68.74view
Vahanian Nicholas N.President, Chief Medical Offic 2015-09-11Sell10,000$51.19-78.59view
Vahanian Nicholas N.President, Chief Medical Offic 2015-08-03Sell10,000$51.77-78.83view
Vahanian Nicholas N.President, Chief Medical Offic 2015-07-14Sell20,000$51.14-78.57view

Quarterly/Annual Reports about NLNK:

News about NLNK:

Articles On GuruFocus.com
First Eagle Investment Adds to Stake in NewLink Genetics Feb 03 2016 
These Companies Show High Profit and Low Debt Jun 17 2015 
When A Stock Doubles, Don’t Trim It Automatically May 27 2015 
Greenblatt's Top Buys During First Quarter May 22 2015 
NewLink Genetics Corporation Offers a Risky Way to Generate Income Sep 11 2013 
Weekly CEO Sells Highlight: Universal Insurance Holdings Inc, Avanir Pharmaceuticals Inc, Bel Fuse I Jun 30 2012 

More From Other Websites
NEWLINK GENETICS CORP Files SEC form 8-K, Entry into a Material Definitive Agreement Nov 29 2016
NewLink Genetics Corp. breached its 50 day moving average in a Bearish Manner : NLNK-US : November... Nov 22 2016
Edited Transcript of NLNK earnings conference call or presentation 1-Nov-16 12:30pm GMT Nov 21 2016
NEWLINK GENETICS CORP Financials Nov 16 2016
Corbus Pharma Bear Thesis Is Alive and Well on Sclerosis Drug Data Skewed Positive Nov 15 2016
NewLink Genetics to Participate in Three Investor Conferences in November Nov 09 2016
NewLink Genetics to Participate in Three Investor Conferences in November Nov 09 2016
NEWLINK GENETICS CORP Files SEC form 10-Q, Quarterly Report Nov 08 2016
ETF’s with exposure to NewLink Genetics Corp. : November 3, 2016 Nov 03 2016
NewLink Genetics Corp. :NLNK-US: Earnings Analysis: Q3, 2016 By the Numbers : November 2, 2016 Nov 02 2016
NewLink reports 3Q loss Nov 01 2016
NewLink reports 3Q loss Nov 01 2016
NEWLINK GENETICS CORP Files SEC form 8-K, Results of Operations and Financial Condition Nov 01 2016
NewLink Genetics Corporation Provides Operational Update and Reports Third Quarter 2016 Financial... Nov 01 2016
NewLink Genetics Corporation Provides Operational Update and Reports Third Quarter 2016 Financial... Nov 01 2016
Q3 2016 NewLink Genetics Corp Earnings Release - Before Market Open Nov 01 2016
NewLink Genetics Corp. breached its 50 day moving average in a Bearish Manner : NLNK-US : October... Oct 31 2016
NEWLINK GENETICS CORP Files SEC form 8-K, Other Events Oct 25 2016
NewLink Genetics Shares Its Immuno-Oncology Strategy 2016 Analyst and Investor Day Oct 25 2016
NewLink Genetics to Host Its Third Quarter 2016 Financial Results Conference Call on November 1,... Oct 24 2016

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)